Watanabe T, Shinohara N, Moriya K, Sazawa A, Kobayashi Y, Ogiso Y, Takiguchi M, Yasuda J, Koyanagi T, Kuzumaki N, Hashimoto A
Department of Veterinary Clinical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
IUBMB Life. 2000 Apr;49(4):317-20. doi: 10.1080/15216540050033195.
The epidermal growth factor (EGF) receptor has been suggested to have an important role in tumor initiation and progression of human bladder cancers. Grb2 protein, which is the downstream effector of the EGF receptor, acts as an adaptor protein between the EGF receptor and the Ras guanine-nucleotide exchange factor, son of sevenless (Sos) protein. Sos protein regulates the action of Ras protein by promoting the exchange of GDP for GTP. However, the significance of Grb2 and Sos proteins, which is related to EGF-triggered Ras activation, has not been elucidated in human bladder cancer. The aim of the present study is to clarify the significance of these proteins in human bladder cancer cell lines. In the present study, we used four human bladder cancer cell lines (T24, KU-7, UMUC-2, UMUC-6) and two kinds of cultured normal urothelial cells (HMKU-1, HMKU-2) isolated from patients with no malignancy. We examined the expression of EGF receptor, Grb2, and Sos proteins in these cells by Western blot analysis. Furthermore, the bladder cancer cell lines were subjected to sequence analysis to identify a point mutation in the c-H-ras gene at codon 12. There was no marked difference in the expression of the EGF receptor between human bladder cancer cell lines and cultured normal urothelial cells. On the other hand, expression of Grb2 and Sos proteins was substantially increased in all human bladder cancer cell lines examined in comparison with cultured normal urothelial cells, whether codon 12 of H-ras was mutated or not. These results suggest that the amplification of both Grb2 and SOS proteins plays an important role in the carcinogenesis of human bladder cancer.
表皮生长因子(EGF)受体被认为在人类膀胱癌的肿瘤起始和进展中起重要作用。Grb2蛋白是EGF受体的下游效应器,作为EGF受体与Ras鸟嘌呤核苷酸交换因子——七号less之子(Sos)蛋白之间的衔接蛋白。Sos蛋白通过促进GDP与GTP的交换来调节Ras蛋白的作用。然而,在人类膀胱癌中,与EGF触发的Ras激活相关的Grb2和Sos蛋白的意义尚未阐明。本研究的目的是阐明这些蛋白在人类膀胱癌细胞系中的意义。在本研究中,我们使用了四种人类膀胱癌细胞系(T24、KU-7、UMUC-2、UMUC-6)以及从无恶性肿瘤患者中分离出的两种培养的正常尿路上皮细胞(HMKU-1、HMKU-2)。我们通过蛋白质印迹分析检测了这些细胞中EGF受体、Grb2和Sos蛋白的表达。此外,对膀胱癌细胞系进行序列分析以鉴定c-H-ras基因第12密码子处的点突变。人类膀胱癌细胞系与培养的正常尿路上皮细胞之间EGF受体的表达没有显著差异。另一方面,与培养的正常尿路上皮细胞相比,在所有检测的人类膀胱癌细胞系中,无论H-ras的第12密码子是否突变,Grb2和Sos蛋白的表达均显著增加。这些结果表明,Grb2和SOS蛋白的扩增在人类膀胱癌的致癌过程中起重要作用。